Science
Mechanism of Action
This ingredient functions principally as a synthetic colorant. As Gentian Violet, it also acts as an antiseptic by disrupting microbial cell wall formation, inhibiting glutamine and protein synthesis, altering redox potential, and targeting specific microbial enzymes. In mammalian cells, it modulates inflammation by blocking NADPH oxidases, thereby decreasing superoxide conversion, inhibiting NFkB, and exhibiting anti-inflammatory effects. The dye’s ionic components interact with negatively charged microbial elements like lipopolysaccharide and DNA, also demonstrating antimitotic activity.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 A 0.3% concentration significantly reduced Staphylococcus aureus density and clinical severity of eczema after 4 days.
- 02 A 0.5% concentration was observed to reduce skin damage in irritative dermatitis.
Transparency
Dusting Analysis
While clinically effective concentrations for its antiseptic and anti-inflammatory benefits range from 0.3% to 0.5%, the Scientific Committee on Consumer Safety (SCCS) limits its concentration in cosmetic products intended for brief skin contact to a maximum of 0.0005% (5 ppm). This significant disparity means that if CI 42520 were included in a typical skincare product for its purported benefits, it would likely be 'dusted' at sub-efficacious levels to comply with regulatory guidelines for cosmetic colorants, rendering any claimed therapeutic benefit unsubstantiated for cosmetic use.
The Formula
Formulation
Stability
Studies on photocatalytic degradation indicate broad stability from pH 3 to 13, with minimal degradation variability (within 2%) across this range.
Conflicts
- Not recommended for application on mucous membranes or open wounds.
- Associated with irritant contact dermatitis in 3% preparations, particularly on intertriginous areas or with prolonged contact.
- Not to be used with foodstuffs, pharmaceutical products, or for household purposes.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel indicates insufficient safety data for CI 42520 (Basic Violet 1, 3, and 4) in cosmetics, citing carcinogenic potential and a need for dermal absorption data and risk assessment. The SCCS permits Basic Violet 2 (CI 42520) up to 0.5-1.0% in hair dyes but only 0.0005% (5 ppm) in other cosmetic products intended for brief skin contact. While animal studies suggest potential carcinogenicity with high oral doses, no human cancer reports are linked to topical use. EWG's Skin Deep notes 'Possible human carcinogen' (EU GHS codes) but generally rates cancer concern 'LOW'; however, 'EWG VERIFIED products cannot contain this ingredient'. Reports of irritant contact dermatitis exist with 3% concentrations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While CI 42520 demonstrates documented antimicrobial and anti-inflammatory potential, its safety profile is deemed insufficient by regulatory bodies due to carcinogenic concerns, and its effective concentrations for therapeutic benefits far exceed the extremely low maximum permitted in cosmetic products for skin contact, making its inclusion in precision skincare for functional benefit highly questionable.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources